Variation in gene expression patterns in follicular lymphoma and the response to rituximab

作者: Sean P Bohen , Olga G Troyanskaya , Orly Alter , Roger Warnke , David Botstein

DOI: 10.1073/PNAS.0437875100

关键词:

摘要: Analysis of the patterns gene expression in follicular lymphomas from 24 patients suggested that two groups tumors might be distinguished. All patients, whose biopsies were obtained before any treatment, treated with rituximab, a monoclonal antibody directed against B cell antigen, CD20. Gene subsequently failed to respond rituximab appeared more similar those normal lymphoid tissues than responders. These findings suggest possibility response lymphoma treatment may predicted pattern tumors.

参考文章(17)
Josée Golay, Luisella Zaffaroni, Thomas Vaccari, Manuela Lazzari, Gian-Maria Borleri, Sergio Bernasconi, Francesco Tedesco, Alessandro Rambaldi, Martino Introna, Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis Blood. ,vol. 95, pp. 3900- 3908 ,(2000) , 10.1182/BLOOD.V95.12.3900
Daming Shan, Jeffrey A. Ledbetter, Oliver W. Press, Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies Blood. ,vol. 91, pp. 1644- 1652 ,(1998) , 10.1182/BLOOD.V91.5.1644
P McLaughlin, A J Grillo-López, B K Link, R Levy, M S Czuczman, M E Williams, M R Heyman, I Bence-Bruckler, C A White, F Cabanillas, V Jain, A D Ho, J Lister, K Wey, D Shen, B K Dallaire, Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Journal of Clinical Oncology. ,vol. 16, pp. 2825- 2833 ,(1998) , 10.1200/JCO.1998.16.8.2825
Andreas Rosenwald, George Wright, Wing C. Chan, Joseph M. Connors, Elias Campo, Richard I. Fisher, Randy D. Gascoyne, H. Konrad Muller-Hermelink, Erlend B. Smeland, Jena M. Giltnane, Elaine M. Hurt, Hong Zhao, Lauren Averett, Liming Yang, Wyndham H. Wilson, Elaine S. Jaffe, Richard Simon, Richard D. Klausner, John Powell, Patricia L. Duffey, Dan L. Longo, Timothy C. Greiner, Dennis D. Weisenburger, Warren G. Sanger, Bhavana J. Dave, James C. Lynch, Julie Vose, James O. Armitage, Emilio Montserrat, Armando López-Guillermo, Thomas M. Grogan, Thomas P. Miller, Michel LeBlanc, German Ott, Stein Kvaloy, Jan Delabie, Harald Holte, Peter Krajci, Trond Stokke, Louis M. Staudt, The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma The New England Journal of Medicine. ,vol. 346, pp. 1937- 1947 ,(2002) , 10.1056/NEJMOA012914
M. E. Garber, O. G. Troyanskaya, K. Schluens, S. Petersen, Z. Thaesler, M. Pacyna-Gengelbach, M. van de Rijn, G. D. Rosen, C. M. Perou, R. I. Whyte, R. B. Altman, P. O. Brown, D. Botstein, I. Petersen, Diversity of gene expression in adenocarcinoma of the lung Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 13784- 13789 ,(2001) , 10.1073/PNAS.241500798
Guillaume Cartron, Laurent Dacheux, Gilles Salles, Philippe Solal-Celigny, Pierre Bardos, Philippe Colombat, Hervé Watier, Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene Blood. ,vol. 99, pp. 754- 758 ,(2002) , 10.1182/BLOOD.V99.3.754
Daming Shan, Jeffrey A. Ledbetter, Oliver W. Press, Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells. Cancer Immunology, Immunotherapy. ,vol. 48, pp. 673- 683 ,(2000) , 10.1007/S002620050016
David G Maloney, Barbara Smith, Andrea Rose, Rituximab: Mechanism of action and resistance Seminars in Oncology. ,vol. 29, pp. 2- 9 ,(2002) , 10.1053/SONC.2002.30156
Troyanskaya Olga, Cantor Michael, Shelock Gavin, Brown Pat, Hastie Trevor, Tibshirani Robert, Botstein David, None, Missing value estimation methods for DNA microarrays. Bioinformatics. ,vol. 17, pp. 520- 525 ,(2001) , 10.1093/BIOINFORMATICS/17.6.520